We are an experienced cutting edge Toxicology and Molecular healthcare lab offering comprehensive laboratory testing backed by innovative science and excellent service.

CLIA Certified & CAP Accredited

Who we are

We are a leading-edge Toxicology and Molecular Diagnostics company founded in 2015 by Phd’s and MD’s, specializing in biotech development. Based in the suburbs of Chicago, our mission is to deliver innovative and valuable healthcare testing solutions to the community we serve. With state-of-the-art technology and a commitment to excellence, we aim to redefine healthcare standards through precision and innovation.

Our Core Values

Community Engagement

Engaging with the local community through outreach programs or initiatives to promote health awareness and provide support.

Innovation in Testing

Continuously introducing advanced and accurate testing methodologies, staying ahead of industry standards.

Customized Solutions

Tailoring testing options to cater specifically to the needs of the community, ensuring precise and personalized diagnostics.

Timely and Accurate Results

Ensuring quick turnaround times for test results without compromising accuracy, aiding prompt decision-making for healthcare providers. We offer industry leading turn times as well as courier services within the Chicago area.

Educational Initiatives

Offering resources, seminars, or workshops to inform and educate healthcare professionals and the community about the importance and implications of various tests.

Collaboration and Support

Collaborating with healthcare providers to offer guidance and support, ensuring they can effectively leverage test results for patient care.

Continuous Improvement

Regularly upgrading equipment and methodologies to maintain cutting-edge standards and accuracy in diagnostics.

Selected Articles and Presentations

Published articles or presentation abstracts that used or cited the tests developed by American Molecular Laboratories.

Moss SF, Dang LP, Chua D, Sobrado J, Zhou Y, Graham DY. Comparable results of Helicobacter pylori Antibiotic Resistance Testing of Stools versus Gastric Biopsies using Next Generation Sequencing. Gastroenterology. 2022 June; 162(7):2095-2097
Graham DY, Moss SF. Antimicrobial Susceptibility Testing for Helicobacter pylori Is Now Widely Available: When, How, Why. Am J Gastroenterology 2022;117:524–528
Hulten KG, Genta RM, Kalfus IN, Zhou Y, Zhang H, Graham DY. Comparison of Culture with Antibiogram to Next-Generation Sequencing Using Bacterial Isolates and Formalin-Fixed, Paraffin-Embedded Gastric Biopsies. Gastroenterology. 2021 Nov;161(5):1433-1442
Argueta EA, Alsamman MA, Moss SF, D'Agata EMC. Impact of Antimicrobial Resistance Rates on Eradication of Helicobacter pylori in a US Population. Gastroenterology. 2021 May;160(6):2181-2183.
Shiotani A, Roy P, Lu H, Graham DY. Helicobacter pylori diagnosis and therapy in the era of antimicrobial stewardship. Therap Adv Gastroenterology. 2021 Dec 21;14:1-19
Lee YC, Dore MP, Graham DY. Diagnosis and Treatment of Helicobacter pylori Infection. Annu Rev Med. 2022 Jan 27;73:183-195
Zhou Y., Kakuturu R., and Jung D. (LB14). A novel comprehensive method for detection and analysis of antibiotic resistance gene variations in h. pylori from the FFPE gastric biopsies. United European Gastroenterol J. 2016 Dec; 4(6): 800–811
Garcia, Nelson; Leavitt, James; McCarty, Curtis L. III. Use of Helicobacter pylori Antibiotic Resistance Testing on Paraffin Embedded Gastric Biopsy Tissue (Abstract 2711). American Journal of Gastroenterology: October 2018 - Volume 113 - Issue - p S1512-S1513.
Williams, Jonathan; Mientus, Thomas; Patel, Yogesh. Use of Helicobacter pylori Antibiotic Resistance Testing on Paraffin Embedded Gastric Biopsy Tissue (Abstract 2717). American Journal of Gastroenterology: October 2018 - Volume 113 - Issue - p S1516.
Boudreau, Jessica; Zhou, Yi; Zhang, Hongjun; Kakuturu, Rajarao V. Comparison of HLA DQA1 and DQB1 Genes by Multiplex Ligation-Dependent Probe Amplification and Next Generation Sequencing Technologies for Celiac Disease Risk Determination (Abstract 1178). American Journal of Gastroenterology: October 2017 - Volume 112 - Issue - p S647-S648.